Related Experiment Video
Updated: Jan 31, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Effects of Voluntary Agonist-Antagonist Coactivation on Stability of Vertical Posture
Momoko Yamagata1,2, Ali Falaki1, Mark L Latash1
11 The Pennsylvania State University.
Abstract:
We explored the effects of voluntary coactivation of agonist-antagonist leg and trunk muscles on stability of vertical posture. Young healthy subjects performed several tasks while standing with no additional muscle coactivation, low coactivation, and high coactivation. Postural stability was estimated using indices of postural sway and of intertrial variance in the space of muscle groups with parallel scaling of activation levels (M-modes). An increase in coactivation led to a significant increase in the postural sway speed reflected in faster rambling and trembling trajectories. Coactivation also led to a relative drop in the variance component that had no effects on the center of pressure coordinate and an increase in the component that shifted the center of pressure. We conclude that additional muscle coactivation does not help to stabilize vertical posture and is more likely to lead to postural destabilization. The results are consistent with an earlier hypothesis on muscle coactivation ensuring abundance (excessive degrees of freedom) at the level of control variables.
Related Concept Videos
Vertical Curve: Problem Solving
Nuclear Stability
To hold positively charged protons together...
RNA Stability
Introduction to Vertical Curves
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

